Skip to content

High cholesterol simulated.

What happens to 1,000 men with high LDL over a lifetime?

Had a heart attack or stroke
0

Had a heart attack or stroke.

Fatal heart attack or stroke
0

Died from a heart attack or stroke.

Waiting for simulation

Model follows 1,000 hypothetical men with high LDL (160 mg/dL) from age 30 to age 85. To isolate the impact of high cholesterol, deaths from other causes are omitted.

What this shows

Risks can be hard to make sense of when they’re just numbers. This simulation makes the risk of high cholesterol tangible by following 1,000 men with high LDL cholesterol (160 mg/dL) from age 30 to 85, showing heart attacks and strokes as they happen. It then re-rolls the dice but with LDL lowered to 90 mg/dL. Lowering cholesterol early prevents many heart attacks, strokes, and deaths.

How it works

This is a Monte Carlo simulation, run year by year: for each subject, each year, we roll dice weighted by likelihood.

Baseline risk. A high-LDL man’s lifetime chance of a heart attack or stroke, about 23% here, is built from the American Heart Association’s PREVENT equations. Of the events that occur, about 22% are fatal, including sudden deaths outside the hospital.

Lowering LDL early and holding it low cuts lifetime risk to about 16%. The reduction figure comes from large statin trials, which find that risk tracks cumulative LDL exposure.

Caveats: This simulation follows a cohort who don’t die of anything else, to isolate the impact of high cholesterol specifically. Real lives carry other risks the model leaves out — someone who would have had a heart attack at 80 might die of cancer at 70. It’s also male-specific; baseline risk for women is lower. Individual risk depends on many factors; this simulation aims to convey the magnitude of risk that high cholesterol poses (and the risk reduction from treating it) in a more intuitive fashion than numbers alone can provide.

Sources

  1. Khan SS et al., Circulation 2024: Development and Validation of the American Heart Association Predicting Risk of CVD EVENTs (PREVENT) Equations

    The PREVENT base equations estimate 10-year and 30-year risk of atherosclerotic cardiovascular disease (heart attack and stroke) from age, sex, non-HDL cholesterol, blood pressure and its treatment, diabetes, smoking, body-mass index, and kidney function (eGFR), validated across ages 30 to 79.

  2. Cholesterol Treatment Trialists’ Collaboration, Lancet 2010/2012: Efficacy and safety of LDL-lowering with statins

    Meta-analysis (~170,000 participants across 26 trials): roughly 21-22% fewer major vascular events per 1 mmol/L LDL reduction, sustained year after year, with no LDL threshold below which benefit disappears. Relative reduction; absolute benefit scales with baseline risk.

  3. Chou et al. (USPSTF evidence review), JAMA 2022: Statin use for the primary prevention of cardiovascular disease in adults

    USPSTF evidence review of statins for primary prevention (22 trials, n=90,624): relative reductions of about 33% for heart attack and about 22% for stroke, with an all-cause-mortality number-needed-to-treat around 286 over the few-year trial horizons. Absolute reductions over those horizons are small (roughly 0.4 to 0.9%) and grow with longer treatment.

  4. Ference et al., JACC 2012: Effect of long-term exposure to lower LDL cholesterol beginning early in life

    Mendelian randomization (about 312,000 people) showing that cardiovascular risk tracks cumulative LDL exposure — level multiplied by duration — not just current level. There is no validated "LDL-years" calculator; the relationship is directional, not a personal risk score.

This simulation is one piece of a Calypta flow: a guided conversation that helps you think through the decision and answers your questions. Go through the full flow yourself, or bring Calypta to your practice.

Start the conversation

Free · private · no account needed

For your practice

Bring these conversations to your patients.